Yury Verlinsky

Yury Verlinsky

Auto-generated profile, based on publicly available information

Yury Verlinsky

Reproductive Genetics Institute, 2825 North Halsted Street, Chicago, IL 60657, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2001 in JAMA
Verified
Journal Article
Open access
PDF file
YVYury Verlinsky
Yury Verlinsky
SRSvetlana Rechitsky
Svetlana Rechitsky
WSWilliam Schoolcraft
William Schoolcraft
CSCharles Strom
Charles Strom
AKAnver Kuliev
Anver Kuliev
Preimplantation genetic diagnosis (PGD) was introduced for couples at high risk for producing progeny with genetic disorders to avoid prenatal diagnosis followed by pregnancy termination.1,2 Preimplantation genetic diagnosis has become an alternative to traditional prenatal genetic diagnosis and also an integral part of assisted reproduction, providing an important tool for improving the efficiency of in vitro fertilization (IVF) through avoiding the transfer of aneuploid embryos.3,4 Preimplantation genetic diagnosis has been performed in more than 2500 clinical cycles for at-risk couples, resulting in approximately 600 clinical pregnancies and births of at least 500 healthy children.5-10

1 January 2004 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
NSNick Strelchenko
Nick Strelchenko
OVOleg Verlinsky
Oleg Verlinsky
VKValeri Kukharenko
Valeri Kukharenko
YVYury Verlinsky
Yury Verlinsky

1 January 2002 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
SRSvetlana Rechitsky
Svetlana Rechitsky
OVOleg Verlinsky
Oleg Verlinsky
ACAnna Chistokhina
Anna Chistokhina
TSTatyana Sharapova
Tatyana Sharapova
SOSeckin Ozen
Seckin Ozen
YVYury Verlinsky
Yury Verlinsky

1 September 2004 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
AKAnver Kuliev
Anver Kuliev
YVYury Verlinsky
Yury Verlinsky
Direct testing of the outcome of the first and second meiotic divisions has become possible with the introduction of preimplantation genetic diagnosis (PGD) for aneuploidies. Testing of oocytes by fluorescent in situ hybridization (FISH) analysis of the first and second polar bodies showed that more than half of oocytes from the IVF patients aged 35 years and older had chromosomal abnormalities, which originated from errors in meiosis I or meiosis II, or both: 41.9% of oocytes were aneuploid after meiosis I and 37.3% aneuploid after meiosis II, with 29.1% of these oocytes having both meiosis I and meiosis II errors. As a result, one third of oocytes detected as normal after meiosis I contained the meiosis II errors, and two thirds of those with meiosis II errors were already abnormal following meiosis I. Although the rates of chromosomal abnormalities deriving from meiosis I and II were comparable, meiosis I errors predominantly resulted in extra chromosome (chromatid) material in oocytes, in contrast to a random distribution of extra and missing chromatids after meiosis II. The majority of meiosis I abnormalities were represented by chromatid errors, which seem to be the major source of chromosomal abnormalities in the resulting embryos. Approximately one third of aneuploid oocytes deriving from sequential errors in the first and second meiotic divisions resulted in a balanced karyotype, representing a possible phenomenon of “aneuploidy rescue” during the second meiotic division. However, the majority of the embryos resulting from such oocytes appeared to be abnormal for the same or different chromosome(s), or were mosaic, suggesting a possible predisposition of the resulting embryos to further mitotic errors. Although the origin of a high frequency of mosaicism at the cleavage stage is not sufficiently understood, the mosaic embryos may originate from the chromosomally abnormal oocytes, as a result of a “trisomy rescue” mechanism during the first mitotic divisions, which renders polar body FISH analysis to have important clinical value for reliable pre-selection of aneuploidy-free embryos for transfer.

27 February 2002 in JAMA
Verified
Journal Article
Closed access
PDF file
YVYury Verlinsky
Yury Verlinsky
SRSvetlana Rechitsky
Svetlana Rechitsky
OVOleg Verlinsky
Oleg Verlinsky
CMChristina Masciangelo
Christina Masciangelo
KLKevin Lederer
Kevin Lederer
AKAnver Kuliev
Anver Kuliev
Research from JAMA — Preimplantation Diagnosis for Early-Onset Alzheimer Disease Caused by V717L Mutation — ContextIndications for preimplantation genetic diagnosis (PGD) have recently been expanded to include disorders with genetic predisposition to allow only embryos free of predisposing genes to be preselected for transfer back to patients, with no potential for pregnancy termination.ObjectiveTo perform PGD for early-onset Alzheimer disease (AD), determined by nearly completely penetrant autosomal dominant mutation in the amyloid precursor protein (APP) gene.DesignAnalysis undertaken in 1999-2000 of DNA for the V717L mutation (valine to leucine substitution at codon 717) in the APP gene in the first and second polar bodies, obtained by sequential sampling of oocytes following in vitro fertilization, to preselect and transfer back to the patient only the embryos that resulted from mutation-free oocytes.SettingAn in vitro fertilization center in Chicago, Ill.PatientsA 30-year-old AD-asymptomatic woman with a V717L mutation that was identified by predictive testing of a family with a history of early-onset AD.Main Outcome MeasuresResults of mutation analysis; pregnancy outcome.ResultsFour of 15 embryos tested for maternal mutation in 2 PGD cycles, originating from V717L mutation–free oocytes, were preselected for embryo transfer, yielding a clinical pregnancy and birth of a healthy child free of predisposing gene mutation according to chorionic villus sampling and testing of the neonate's blood.ConclusionThis is the first known PGD procedure for inherited early-onset AD resulting in a clinical pregnancy and birth of a child free of inherited predisposition to early-onset AD.

1 February 1999 in Fertility and Sterility
Verified
Journal Article
Closed access
PDF file
JCJeanine Cieslak
Jeanine Cieslak
VIVictor Ivakhnenko
Victor Ivakhnenko
GWGeorg Wolf
Georg Wolf
SSSvetlana Sheleg
Svetlana Sheleg
YVYury Verlinsky
Yury Verlinsky